Clinical trials can test effectiveness

Your feature on the introduction of the Alzheimer's drug, donepezil, in the Withington Hospital, Manchester, ('Making introductions', pages 28-29, 25 February) stated that 'evidence of its efficacy in clinical use and its cost-effectiveness can only be obtained from further research and audit after its introduction in clinical practice'.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here